N/A
N=286
Caregiver Outlook: An Intervention to Improve Caregiving in Serious Illness
Heart Failure · Pulmonary Disease · Cancer
Bottom Line
View on ClinicalTrials.gov: NCT01672294 ↗Enrolled (actual)
286
Serious AEs
8.4%
Results posted
Apr 2017
Primary outcome: Primary: Caregiver Anxiety — 6.9; 7.3; 5.9; 5.4 units on a scale — p=<0.511
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Preparation and life completion (Other); Attention Control (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Caregiver Anxiety |
6.9; 7.3; 5.9; 5.4; 5.8; 6.4 | <0.511 |
| SECONDARY Spirituality |
35.4; 37.3; 36.1; 37.3; 37.3; 36.6 | 0.5225 |
| SECONDARY Depression |
8.2; 8.8; 8.7; 8.0; 8.3; 9.0 | <0.3332 |
| SECONDARY Patient Days of VA Hospital Use |
4.4; 4.4 | 0.8748 |
| SECONDARY Caregiver Burden |
4.2; 4.2; 4.2; 4.2; 4.2; 4.1 | 0.7687 |
| SECONDARY Caregiver Completion |
2.7; 2.8; 2.5; 2.6; 2.5; 2.7 | 0.9221 |
| SECONDARY Prolonged Grief - Number of Participants With Anticipatory Grief |
6; 2; 2; 3; 2; 2 | — |
| SECONDARY Caregiver Preparation |
2.7; 2.4; 2.4; 2.7; 2.6; 2.6 | — |
Summary
Informal caregivers provide a majority of care for patients during serious illness. Lack of preparation and completion may leave caregivers less capable of caring for a loved one or making crucial decisions influencing care.
This study will examine whether a preparation and completion intervention reduces caregiver anxiety, depression, anticipatory grief, and burden and improves patient quality of life and health care use.
Eligibility Criteria
Inclusion Criteria
- Patients with advanced cancer/Congestive heart failure/COPD/End stage renal disease who have a primary caregiver. Caregivers of Durham VAMC patients with advanced disease.
Exclusion Criteria
- No caregiver present.
- Caregiver with Cognitive impairment/inability to speak on phone/non-English speaking
Data sourced from ClinicalTrials.gov (NCT01672294). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.